Kura Oncology to Report Fourth Quarter and Full Year 2022
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the......
Arbutus to Report Fourth Quarter and Year End 2022
WARMINSTER, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging......
Intellia Therapeutics to Hold Conference Call to Discuss
CAMBRIDGE, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on......
Limited Time Offer: Gain second citizenship in St Kitts and
Basseterre, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The luxurious island of St Kitts and Nevis is offering investors the chance to gain coveted second......
Spirit Blockchain announces a strategic investment in
Pixel will partner with Spirit Blockchain to bring a next generation Stablecoin and Capital Markets infrastructure to the global market......
Decibel Therapeutics to Present at the Upcoming SVB
BOSTON, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and......
Shattuck Labs to Report Fourth-Quarter and Full-Year 2022
AUSTIN, TX & DURHAM, NC, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company......